肝细胞癌小鼠模型构建的研究进展

doi:10.11904/j.issn.1002-3070.2024.05.010

摘要/Abstract

摘要： 构建符合人类肝癌生物学特性的实验小鼠模型,对于了解肝癌的发病机制和测试新的治疗药物至关重要。目前,实验室常用的肝癌小鼠模型从构建方法上主要分为化学/饮食诱导小鼠模型、基因工程小鼠模型和移植小鼠模型三种类型。同时这三种类型的肝癌小鼠在构建方式、适用范围和肝癌组织类型的特点上也都各不相同。本综述描述不同肝癌小鼠模型的构建方式、成瘤时间以及适用范围,旨在为研究者在选取小鼠模型方面提供参考。

关键词: 肝细胞癌, 小鼠, 动物模型

Abstract: The constructing experimental mouse models that conform to the biological characteristics of human liver cancer are crucial for understanding the pathogenesis of liver cancer and testing new therapeutic drugs.At present,the commonly used laboratory mouse models for liver cancer are mainly divided into three types based on their construction methods:chemically/diet-induced mouse models,genetically engineered mouse models,and transplanted mouse models.However,these three types of liver cancer mice also differ in their construction methods,scope of application,and characteristics of liver cancer tissue types.This review describes the differences in construction methods,tumor formation time,and applicability among different liver cancer mouse models,aiming to provide a reference for researchers in selecting suitable mouse models.

Key words: Hepatocellular carcinoma, Mouse, Animal model

中图分类号:

R735.7

关勇宇, 聂昊, 张翀. 肝细胞癌小鼠模型构建的研究进展[J]. 实用肿瘤学杂志, 2024, 38(5): 342-348.

GUAN Yongyu, NIE Hao, ZHANG Chong. Research progress of hepatocellular carcinoma mouse models[J]. Journal of Practical Oncology, 2024, 38(5): 342-348.

参考文献

1 Zhang Y,Huang H,Jin L,et al.Anticarcinogenic effects of isothiocyanates on hepatocellular carcinoma[J].Int J Mol Sci,2022,23(22):13834-13847.
2 Friemel J,Frick L,Unger K,et al.Characterization of HCC mouse models:towards an etiology-oriented subtyping approach[J].Molecular Cancer Research,2019,17(7):1493-1502.
3 Kurma K,Manches O,Chuffart F,et al.DEN-Induced rat model reproduces key features of human hepatocellular carcinoma[J].Cancers,2021,13(19):4981-4992.
4 Gu CY,Lee TKW.Preclinical mouse models of hepatocellular carcinoma:an overview and update[J].Exp Cell Res,2022,412(2):113042-113054.
5 Yamada S,Takashina Y,Watanabe M,et al.Bile acid metabolism regulated by the gut microbiota promotes non-alcoholic steatohepatitis-associated hepatocellular carcinoma in mice[J].Oncotarget,2018,9(11):9925-9939.
6 Zhang HE,Henderson JM,Gorrell MD.Animal models for hepatocellular carcinoma[J].Biochim Biophys Acta Mol Basis Dis,2019,1865(5):993-1002.
7 王靳琎,李雪莹,易进科,等.小鼠原发性肝癌模型的建立[J].中国应用生理学杂志,2022,38(6):820-823.
8 Connor F,Rayner TF,Aitken SJ,et al.Mutational landscape of a chemically-induced mouse model of liver cancer[J].J Hepatol,2018,69(4):840-850.
9 Dow M,Pyke RM,Tsui BY,et al.Integrative genomic analysis of mouse and human hepatocellular carcinoma[J].Proc Natl Acad Sci U S A,2018,115(42):9879-9888.
10 Fu H,Tang B,Lang J,et al.High-fat diet promotes macrophage-mediated hepatic inflammation and aggravates diethylnitrosamine-induced hepatocarcinogenesis in mice[J].Front Nutr,2020,7(1):585306-585317.
11 黄梓涵,孔亮,严艾文,等.楮实子水提物对二乙基亚硝胺诱发小鼠肝细胞癌的抑制作用及PTEN/PI3K/Akt信号通路的影响[J].中国实验方剂学杂志,2023,29(22):29-36.
12 屈琳琳,刘彦楠,范代娣.人参皂苷Rg5通过诱导凋亡抑制原发性肝癌小鼠肿瘤生长[J].生物加工过程,2023,21(5):582-588.
13 Memon A,Pyao Y,Jung Y,et al.A modified protocol of diethylnitrosamine administration in mice to model hepatocellular carcinoma[J].Int J Mol Sci,2020,21(15):1-14.
14 González-Romero F,Mestre D,Aurrekoetxea I,et al.E2F1 and E2F2-Mediated Repression of CPT2 Establishes a Lipid-Rich Tumor-Promoting Environment[J].Cancer Res,2021,81(11):2874-2887.
15 Li E,Lin L,Chen CW,et al.Mouse models for immunotherapy in hepatocellular carcinoma[J].Cancers(Basel),2019,11(11):1-16.
16 冯朵,王靖,蒋勇军,等.肉苁蓉总苷对HepG2肝癌荷瘤小鼠的影响[J].食品科学,2024,45(6):120-129.
17 Zhou H,Du Y,Wei X,et al.DDX56 transcriptionally activates MIST1 to facilitate tumorigenesis of HCC through PTEN-AKT signaling[J].Theranostics,2022,12(14):6069-6087.
18 Okada S,Vaeteewoottacharn K,Kariya R.Application of highly immunocompromised mice for the establishment of patient-derived xenograft(PDX)models[J].Cells,2019,8(8):889-907.
19 He L,Tian DA,Li PY,et al.Mouse models of liver cancer:Progress and recommendations[J].Oncotarget,2015,6(27):23306-23322.
20 Akimoto J,Nakayama M,Takagi S,et al.Improved in vivo subcutaneous tumor generation by cancer cell sheet transplantation[J].Anticancer Res,2018,38(2):671-676.
21 Zhang Y,Zhang GL,Sun X,et al.Establishment of a murine breast tumor model by subcutaneous or orthotopic implantation[J].Oncol Lett,2018,15(5):6233-6240.
22 Ma WK,Voss DM,Scharner J,et al.ASO-Based PKM splice-switching therapy inhibits hepatocellular carcinoma growth[J].Cancer Res,2022,82(5):900-915.
23 Okada S,Vaeteewoottacharn K,Kariya R.Application of Highly immunocompromised mice for the establishment of patient-derived xenograft(PDX)models[J].Cells,2019,8(8):1-18.
24 Xu W,Zhao ZY,An QM,et al.Comprehensive comparison of patient-derived xenograft models in hepatocellular carcinoma and metastatic Liver cancer[J].International journal of medical sciences,2020,17(18):3073-3082.
25 Ito R,Takahashi T,Ito M.Humanized mouse models:Application to human diseases[J].J Cell Physiol,2018,233(5):3723-3728.
26 Hajighasemlou S,Pakzad S,Ai J,et al.Characterization and validation of hepatocellular xcrcinoma(HCC)xenograft tumor as a suitable liver cancer model for preclinical mesenchymal stem cell studies[J].Asian Pac J Cancer Prev,2018,19(6):1627-1631.
27 杨梦莹,段永强,贾育新,等.基于NLRP3/Caspase-1/GSDMD炎性焦亡途径探讨参芪抑瘤方联合顺铂对H22肝癌荷瘤小鼠的作用机制[J].中国实验方剂学杂志,2023,29(21):114-122.
28 李月,李玉瑶,冯海,等.淫羊藿素通过阻断Notch信号通路抑制肝癌增殖[J].中华中医药学刊,2023,41(11):134-137.
29 程艳婷,朱涛,马艳竹,等.麦粒灸通过调控凋亡因子半胱氨酸家族增强环磷酰胺对Hepa1-6肝癌荷瘤小鼠的抗肿瘤作用[J].针刺研究,2023,48(9):914-922.
30 Yuan F,Gao Q,Tang H,et al.Ophiopogonin B targets PTP1B to inhibit the malignant progression of hepatocellular carcinoma by regulating the PI3K/AKT and AMPK signaling pathways[J].Mol Med Rep,2022,25(4):1-10.
31 Yu Z,Guo J,Hu M,et al.Icaritin exacerbates mitophagy and synergizes with doxorubicin to induce immunogenic cell death in hepatocellular carcinoma[J].ACS Nano,2020,14(4):4816-4828.
32 Dai W,Xu L,Yu X,et al.OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism[J].J Hepatol,2020,72(5):909-923.
33 Brown ZJ,Heinrich B,Greten TF.Mouse models of hepatocellular carcinoma:an overview and highlights for immunotherapy research[J].Nat Rev Gastroenterol Hepatol,2018,15(9):536-554.
34 Cigliano A,Pilo MG,Li L,et al.Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis[J].Oncotarget,2017,8(53):90638-90650.
35 Chiu DK,Yuen VW,Cheu JW,et al.Hepatocellular carcinoma cells Up-regulate PVRL1,stabilizing PVR and inhibiting the cytotoxic T-cell response via TIGIT to mediate tumor resistance to PD1 inhibitors in mice[J].Gastroenterology,2020,159(2):609-623.
36 Suda T,Yokoo T,Kanefuji T,et al.Hydrodynamic delivery:characteristics,qpplications,and technological advances[J].Pharmaceutics,2023,15(4):1-22.
37 Kamimura K,Yokoo T,Abe H,et al.Effect of diphtheria toxin-based gene therapy for hepatocellular carcinoma[J].Cancers(Basel),2020,12(2):1-16.
38 Mo Y,Wu Y,Li X,et al.Osthole delays hepatocarcinogenesis in mice by suppressing AKT/FASN axis and ERK phosphorylation[J].Eur J Pharmacol,2020,867(1):172788-172804.

[1]	庞武, 陈莉江, 朱宇, 吴涯昆, 张伟. 血清miRNA-24和miRNA-509在肝细胞癌患者血清中的表达及与预后的关系[J]. 实用肿瘤学杂志, 2023, 37(5): 411-415.
[2]	崔永康, 于承平, 许浩志, 马新宇, 麻勇, 李林强. 营养风险指数在可切除肝细胞癌患者术后并发症及预后预测中的作用[J]. 实用肿瘤学杂志, 2023, 37(3): 243-251.
[3]	殷鼎威, 井杰. 肠道菌群在肝细胞癌中的作用及治疗应用的研究进展[J]. 实用肿瘤学杂志, 2023, 37(3): 281-286.
[4]	王嘉倍, 张运广, 刘连新. 免疫治疗联合分子靶向药物治疗中晚期肝细胞癌的临床疗效及安全性分析:一项单臂回顾性研究[J]. 实用肿瘤学杂志, 2022, 36(6): 489-494.
[5]	刘佳, 杨道坤, 王燕平, 陈宝鑫, 王新伟, 申娇. PD-1抑制剂治疗肝细胞癌疗效相关生物标志物的研究现状[J]. 实用肿瘤学杂志, 2022, 36(4): 374-380.
[6]	刘嘉铭, 崔逸峰, 陆朝阳. 槐耳清膏通过线粒体转录因子A调控Akt信号通路进而抑制肝细胞癌的增殖和转移[J]. 实用肿瘤学杂志, 2022, 36(3): 203-207.
[7]	刘雨, 俞星新, 耿志达, 陈政良, 惠鹏, 梁英健. 成纤维细胞在肝癌发生发展中的作用[J]. 实用肿瘤学杂志, 2022, 36(2): 167-172.
[8]	王宗文, 李小东, 朱乾坤, 曾世聪, 翟博. KIF14在肝细胞癌SMCC-7721获得性耐药机制中的研究[J]. 实用肿瘤学杂志, 2022, 36(1): 14-19.
[9]	刘菲, 隋红. 基于肿瘤免疫微环境的肝癌分子分型研究进展[J]. 实用肿瘤学杂志, 2021, 35(6): 557-561.
[10]	纪雷, 纪道林, 鲍冬冬, 谭刚. lncRNA在肝细胞癌索拉非尼耐药中的最新研究进展[J]. 实用肿瘤学杂志, 2021, 35(6): 562-567.
[11]	赵浩然, 李满, 张玉宝. 肝细胞癌相关RNA结合蛋白研究进展[J]. 实用肿瘤学杂志, 2021, 35(6): 576-579.
[12]	贺玲, 姚克铖. 糖基磷脂酰肌醇转酰胺酶与肝癌[J]. 实用肿瘤学杂志, 2021, 35(5): 458-461.
[13]	曲雁飞, 刘超, 王勃军, 方琳, 张艳桥. CSN6基因在肝细胞癌组织中的表达及临床意义[J]. 实用肿瘤学杂志, 2019, 33(4): 328-333.
[14]	赵凌云, 齐鲁楠, 游雪梅审校. 热休克蛋白70在肝细胞癌中的研究进展[J]. 实用肿瘤学杂志, 2017, 31(6): 528-532.
[15]	王艺潼综述, 徐雯审校. 急性早幼粒细胞白血病小鼠动物模型建立的研究现状[J]. 实用肿瘤学杂志, 2017, 31(5): 454-457.